Multidisciplinary medication review: Evaluation of a pharmaceutical care model for nursing homes

International Journal of Clinical Pharmacy

Volumn 33, Issue 3, 2011, Pages 549-557

  Brulhart, Melanie Isabelle ^a   Wermeille, Joel Pierre ^a  

^a Hospitals and Nursing Homes of Jura and Jura Bernois SA   (Switzerland)

Author keywords

Clinical pharmacist; Drug related problems; Elderly; Medication review; Nursing home; PCNE DRP classification; Polypharmacy; Switzerland

Indexed keywords

ADVERSE DRUG REACTION; AGED; ARTICLE; CONTROLLED STUDY; COST CONTROL; DOSE KIDNEY FUNCTION RELATION; DRUG CHOICE; DRUG COST; DRUG DOSE; DRUG INDICATION; DRUG INTERACTION; DRUG WITHDRAWAL; ELDERLY CARE; FEMALE; HUMAN; INTERDISCIPLINARY COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; MEDICATION ERROR; MEDICATION REVIEW; NURSING HOME; OUTCOME ASSESSMENT; PEER REVIEW; PHARMACEUTICAL CARE; PHARMACIST; POLYPHARMACY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWITZERLAND; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; DRUG INTERACTIONS; DRUG UTILIZATION REVIEW; FEMALE; FOLLOW-UP STUDIES; HOMES FOR THE AGED; HUMANS; MALE; MODELS, STATISTICAL; NURSING HOMES; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; PROSPECTIVE STUDIES;

EID: 79960035182     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9506-1     Document Type: Article

References (37)

1. Swiss Office of Statistics. Press communication no. 0351-0714-50 [document on the internet]. Neuchâtel, Switzerland: Federal Office of Statistics; 2007 Dec 10 [updated 2010 Oct 20; cited 2010 Jan 08]. Available from: Http://www.bfs.admin.ch/bfs/ portal/fr/index/themen/14/22/press.Document. 103082.pdf.
2. Swiss Office of Statistics. Press communication no. 0351-0803-60 [document on the internet]. Neuchâtel, Switzerland: Federal Office of Statistics; 2008 Apr 22 [updated 2010 Oct 20; cited 2010 Jan 08]. Available from: Http://www.bfs.admin.ch/bfs/ portal/fr/index/themen/14/22/press.Document. 106960.pdf.
3. Fontannaz J-R. Les tarifs des homes subissent de fortes variations [Prices in nursing homes are under strong variations]. Bilan [serial on the internet]. 2008 May; [updated 2010 Oct 20; cited 2010 Jan 08]; 250: [about 5 screens]. Available from: Http://www. bilan.ch/argent/les-tarifs-des-homes- subissent-de-fortes-variations.
4. Government of Le Jura Republic. Government information to the Parliament of Le Jura Republic about the future organisation of nursing homes [document on the internet]. Delémont, Switzerland; 2009 Nov 17 [updated 2010 Oct 20; cited 2010 Jan 08]. Available from: Http://www.jura.ch/Htdocs/Files/ Departements/ DSA/SSA/Documents/Messagegeronto.pdf.
5. Grenier-Gosselin L. Portrait de la population gériatrique et médicaments problématiques chez cette clientèle [Elderly patients and drug problems in this population]. Pharmactuel. 2008;41:6-10.
6. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy. 2005;25: 1636-45. (Pubitemid 41566922)
7. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:314-6.
8. Rossi M, Young A, Maher R, Rodriguez K, Appelt C, Perera S, et al. Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother. 2007;5:317-23.
9. Wawruch M, Zikavska M, Wsolova L, Kuzelova M, Tisonova J, Gajdosik J, et al. Polypharmacy in elderly hospitalised patients in Slovakia. Pharm World Sci. 2008;30:235-42. (Pubitemid 351550902)
10. Spinewine A, Swine C, Dhillon S, Franklin BD, Tulkens PM, Wilmotte L, et al. Appropriateness of use of medicines in elderly inpatients: Qualitative study. BMJ [serial on the internet]. 2005 Aug 10; [updated 2010 Oct 20, cited 2005 Nov 02]; 331: 935: [about 10 screens]. Available from: Http://www.bmj.com/ content/ 331/7522/935.full.
11. Beuzit K, Arnaud A, Remblier C, Haas M, Perault M-C. Analyse de prescriptions en institution gériatrique [Prescription analysis in nursing homes]. Journal de Pharmacie Clinique. 2003;22:18-22.
12. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: How well can it be measured and optimised? Lancet. 2007;370: 173-84. (Pubitemid 47049724)
13. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370:185-91. (Pubitemid 47042897)
14. Wynne HA. Adverse drug reactions in old age. Adverse Drug React Bull. 2006;237:907-10. (Pubitemid 46050567)
15. Alcalde E, Guerrero M, Pérez G, Moreno C. Measures to reduce pharmaceutical costs in Spanish nursing homes. EJHP-Sci. 2009;15:20-4.
16. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: A review of the impact of pharmacy services. Ann Pharmacother. 2009;43:1096-106.
17. Ampe E, Spinewine A, Wilmotte L, Hecq J-D, Tulkens PM. La pharmacie clinique: Un développement récent de l'activité des pharmaciens pour une prise en charge optimisée des patients du point de vue médicamenteux [Clinical pharmacy: A recent development of pharmacist activity to optimise patient medication]. Louvain Medical. 2006;125:273-86.
18. Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother. 2004;2(1):3-13. (Pubitemid 38559454)
19. Stuijt CC, Franssen EJ, Egberts AC, Hudson SA. Appropriateness of prescribing among elderly patients in a Dutch residential home: Observational study of outcomes after a pharmacist-led medication review. Drug Aging. 2008;25:947-54.
20. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch Intern Med. 2009;169:894-900.
21. Linnebur SA, O'Conell MB, Wessell AM, McCord AD, Kennedy DH, DeMaagd G, et al. Pharmacy practice, research, education, and advocacy for older adults (ACCP White Paper). Parmacotherapy. 2005;25:1396-430.
22. Perez A, Doloresco F, Hoffman JM, Meek PD, Touchette DR, Vermeulen LC, et al. Economic evaluations of clinical pharmacy services: 2001-2005 (ACCP). Parmacotherapy. 2008;28:285-323.
23. June Gibbs Brown, Inspector general. Prescription drug use in nursing homes [document on the internet]. Texas: Departement of Health and Human Services, Office of inspector general; 1997 Nov. Report 2 [updated 2010 Oct 20; cited 2010 Jan 08]. Available from: Http://oig.hhs.gov/oei/reports/oei-06-96- 00082.pdf.
24. Pharmaceutical Care Network Europe Foundation. PCNE Classification for drug-related problems V5.00 [document on the internet]. 2007 Oct 03; [updated 2010 Oct 20; cited 2006 Aug 2]. Available from: Http://www.pcne.org/dokumenter/ DRP/PCNE %20classification%20V5.00.pdf.
25. Vonbach P, Dubied A, Krähenbühl S, Beer JH. Evaluation of frequently used drug interaction screening programs. Pharm World Sci. 2008;30:367-74.
26. Foppe van Mil JW, Tommy Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859-67. (Pubitemid 38509068)
27. Lampert ML, Krähenbühl S, Hug BL. Drug-related problems: Evaluation of a classification system in the daily pratice of a Swiss university hospital. Pharm World Sci. 2008;30:768-76.
28. Klopfer JD, Einarson TR. Acceptance of pharmacists' suggestions by prescribers: A literature review. Hosp Pharm. 1990;25: 830-6.
29. Montgomery AT, Kälvemark-Sporrong S, Henning M, Tully MP, Kettis-Lindblad A. Implementation of a pharmaceutical care service: Prescriptionists', pharmacists' and doctors' views. Pharm World Sci. 2007;29:593-602. (Pubitemid 47594162)
30. Langebrake C, Hilgarth H. Clinical pharmacists' interventions in a German university hospital. Pharm World Sci. 2010;32:194-9.
31. Benoît P, Mangerel K, Garreau T, Vonna P, Juste M. Evaluation des moyens mis en oeuvre et acceptation d'une présence pharmaceutique dans les services de soins [Evaluation of requirements and acceptance of a pharmaceutical presence in wards]. Journal de Pharmacie Clinique. 2007;26:83-90. (Pubitemid 47035302)
32. Galindo C, Olivé M, Lacasa C, Martinez J, Roure C, Llado M, et al. Pharmaceutical care: Pharmacy involvement in prescribing in acute-care hospital. Pharm World Sci. 2003;25:56-64. (Pubitemid 36547114)
33. Chatsisvili A, Sapounidis I, Pavlidou G, Zoumpouridou E, Karakousis VA, Spanakis M, et al. Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece. Pharm World Sci. 2010;32:187-93.
34. Loca JF, Rüggli M, Buchmann M, Huguenin J, Bugnon O. Development of pharmaceutical care services in nursing homes: Practice and research in a Swiss canton. Pharm World Sci. 2009;31:165-73.
35. Bootman JL, Harrison LDL, Cox E. The health care cost of drugrelated morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157:2089-96. (Pubitemid 27431277)
36. Patterson SM, Hughes CM, Lapane KL. Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom. Pharm World Sci. 2007;29:517-25. (Pubitemid 47389409)
37. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51:257-65. (Pubitemid 32396417)